OnCore Login

Return to Trial Database

HCRN-GI23-643

Randomized Trial of Regorafenib in Combination with Pembrolizumab or Pembrolizumab Monotherapy for Patients with MSI-H Colorectal Cancer

Status

Currently Enrolling

Cancer Type(s)

Colorectal

Study Contact

317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GI23-643 being conducted in.
AdventHealth Orlando
UPMC Hillman Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278